Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice
Abstract Background Lipoprotein glomerulopathy (LPG) is a rare autosomal dominant kidney disease that is most commonly caused by mutations in ApoE Kyoto (p.R43C) and ApoE Sendai (p.R163P). Differences in phenotype among the various ApoE mutations have been suggested, but the pathogenic role of ApoE...
Main Authors: | Hongyan Wu, Jing Yang, Yun-Qiang Liu, Song Lei, Mei Yang, Zhi Yang, Yuan Yang, Zhangxue Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-021-02765-x |
Similar Items
-
Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations
by: Mingxin Yang, et al.
Published: (2020-08-01) -
A Case of Lipoprotein Glomerulopathy with apoE Chicago and apoE (Glu3Lys) Treated with Fenofibrate
by: Hitoshi Kodera, et al.
Published: (2017-07-01) -
ApoE-containing HDL and the development of atherosclerosis
by: Agnieszka Ćwiklińska, et al.
Published: (2015-01-01) -
ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice
by: Emanuel Voyiaziakis, et al.
Published: (1998-02-01) -
Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America
by: Joaquim Nelito da Silveira-Neto, et al.
Published: (2021-07-01)